Exposure-Safety Markov Modeling of Ocular Adverse Events in Patient Populations Treated With Tisotumab Vedotin

The current analysis aimed to characterize exposure-response relationships of TV exposure on the incidence, severity, and longitudinal time course of grade ≥2 ocular adverse events (AEs).